Chart Industries, Inc. (NYSE: GTLS) today reported results for the second quarter 2025 ended June 30, 2025. Second quarter 2025 highlights compared to second quarter 2024: Orders of $1.50 billion, an ...

Despite recent share price underperformance, I maintain a bullish outlook and consider Kinder Morgan a quality 'buy' ...

Chart Industries, Inc. (NYSE: GTLS) today reported results for the second quarter 2025 ended June 30, 2025. Second quarter 2025 highlights compared to second ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

In April 2025, Radiopharm dosed the first patient in the U.S. Phase 2b imaging study of 18F-RAD101. The multicenter, open-label, single arm Phase 2b clinical trial is evaluating the diagnostic ...

Upstream stocks often get the spotlight due to their explosive upside when oil prices surge. But midstream companies may play ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...